170 related articles for article (PubMed ID: 26013697)
1. Minority participation in Gynecologic Oncology Group (GOG) Studies.
Scalici J; Finan MA; Black J; Harmon MD; Nicolson W; Lankes HA; Brady WE; Rocconi RP
Gynecol Oncol; 2015 Aug; 138(2):441-4. PubMed ID: 26013697
[TBL] [Abstract][Full Text] [Related]
2. Not immune to inequity: minority under-representation in immunotherapy trials for breast and gynecologic cancers.
Grette KV; White AL; Awad EK; Scalici JM; Young-Pierce J; Rocconi RP; Jones NL
Int J Gynecol Cancer; 2021 Nov; 31(11):1403-1407. PubMed ID: 34088749
[TBL] [Abstract][Full Text] [Related]
3. Minority participation in phase 1 gynecologic oncology clinical trials: Three decades of inequity.
Awad E; Paladugu R; Jones N; Pierce JY; Scalici J; Hamilton CA; Darcy KM; Maxwell GL; Rocconi RP
Gynecol Oncol; 2020 Jun; 157(3):729-732. PubMed ID: 32173047
[TBL] [Abstract][Full Text] [Related]
4. Underrepresentation of racial and ethnic minority groups in gynecologic oncology: An analysis of over 250 trials.
Richardson MT; Barry D; Steinberg JR; Thirunavu V; Strom DE; Holder K; Zhang N; Turner BE; Magnani CJ; Weeks BT; Young AMP; Lu CF; Wolgemuth TR; Laasiri N; Squires NA; Anderson JN; Karlan BY; Chan JK; Kapp DS; Roque DR; Salani R
Gynecol Oncol; 2024 Feb; 181():1-7. PubMed ID: 38096673
[TBL] [Abstract][Full Text] [Related]
5. Racial and Ethnic Disparities in Clinical Trial Enrollment Among Women With Gynecologic Cancer.
Khadraoui W; Meade CE; Backes FJ; Felix AS
JAMA Netw Open; 2023 Dec; 6(12):e2346494. PubMed ID: 38060227
[TBL] [Abstract][Full Text] [Related]
6. The generalizability of NCI-sponsored clinical trials accrual among women with gynecologic malignancies.
Mishkin G; Minasian LM; Kohn EC; Noone AM; Temkin SM
Gynecol Oncol; 2016 Dec; 143(3):611-616. PubMed ID: 27697287
[TBL] [Abstract][Full Text] [Related]
7. Investigating Black-White disparities in gynecologic oncology: Theories, conceptual models, and applications.
Doll KM
Gynecol Oncol; 2018 Apr; 149(1):78-83. PubMed ID: 29605054
[TBL] [Abstract][Full Text] [Related]
8. Enrollment of Individuals From Racial and Ethnic Minority Groups in Gynecologic Cancer Precision Oncology Trials.
Mattei LH; Robb L; Banning K; Polan RM; Cote ML
Obstet Gynecol; 2022 Oct; 140(4):654-661. PubMed ID: 36075065
[TBL] [Abstract][Full Text] [Related]
9. Gynecologic cancer disparities: a report from the Health Disparities Taskforce of the Society of Gynecologic Oncology.
Collins Y; Holcomb K; Chapman-Davis E; Khabele D; Farley JH
Gynecol Oncol; 2014 May; 133(2):353-61. PubMed ID: 24406291
[TBL] [Abstract][Full Text] [Related]
10. Demographic reporting and language exclusion in gynecologic oncology clinical trials.
Lee SS; Dinicu AI; Arthurs L; Shields D; Pothuri B; Lightfoot MDS
Am J Obstet Gynecol; 2024 Jan; 230(1):73.e1-73.e14. PubMed ID: 37751830
[TBL] [Abstract][Full Text] [Related]
11. Racial and ethnic disparities over time in the treatment and mortality of women with gynecological malignancies.
Rauh-Hain JA; Melamed A; Schaps D; Bregar AJ; Spencer R; Schorge JO; Rice LW; Del Carmen MG
Gynecol Oncol; 2018 Apr; 149(1):4-11. PubMed ID: 29605048
[TBL] [Abstract][Full Text] [Related]
12. Participation in cancer clinical trials: race-, sex-, and age-based disparities.
Murthy VH; Krumholz HM; Gross CP
JAMA; 2004 Jun; 291(22):2720-6. PubMed ID: 15187053
[TBL] [Abstract][Full Text] [Related]
13. Adherence to treatment guidelines as a major determinant of survival disparities between black and white patients with ovarian cancer.
Chen F; Bailey CE; Alvarez RD; Shu XO; Zheng W
Gynecol Oncol; 2021 Jan; 160(1):10-15. PubMed ID: 33208254
[TBL] [Abstract][Full Text] [Related]
14. Racial and ethnic enrollment disparities in clinical trials of poly(ADP-ribose) polymerase inhibitors for gynecologic cancers.
Wagar MK; Mojdehbakhsh RP; Godecker A; Rice LW; Barroilhet L
Gynecol Oncol; 2022 Apr; 165(1):49-52. PubMed ID: 35144798
[TBL] [Abstract][Full Text] [Related]
15. Participation of Patients With Limited English Proficiency in Gynecologic Oncology Clinical Trials.
Jorge S; Masshoor S; Gray HJ; Swisher EM; Doll KM
J Natl Compr Canc Netw; 2023 Jan; 21(1):27-32.e2. PubMed ID: 36634612
[TBL] [Abstract][Full Text] [Related]
16. Diversity and transparency in gynecologic oncology clinical trials.
Montes de Oca MK; Howell EP; Spinosa D; Knochenhauer H; Peipert BJ; Severson E; Ramkissoon S; Akinyemiju TF; Previs RA
Cancer Causes Control; 2023 Feb; 34(2):133-140. PubMed ID: 36284031
[TBL] [Abstract][Full Text] [Related]
17. A Demographic Analysis of Racial/Ethnic Minority Enrollment Into HVTN Preventive Early Phase HIV Vaccine Clinical Trials Conducted in the United States, 2002-2016.
Huamani KF; Metch B; Broder G; Andrasik M
Public Health Rep; 2019; 134(1):72-80. PubMed ID: 30517057
[TBL] [Abstract][Full Text] [Related]
18. Racial and Ethnic Disparities in Primary Open-Angle Glaucoma Clinical Trials: A Systematic Review and Meta-analysis.
Allison K; Patel DG; Greene L
JAMA Netw Open; 2021 May; 4(5):e218348. PubMed ID: 34003274
[TBL] [Abstract][Full Text] [Related]
19. Patterns of National Cancer Institute-Sponsored Clinical Trial Enrollment in Black Adolescents and Young Adults.
Roth M; Beauchemin M; Kahn JM; Bleyer A
Cancer Med; 2021 Nov; 10(21):7620-7628. PubMed ID: 34592782
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of women with gynecologic cancer who enter clinical trials.
Luck MB; McIntire M; Blades N; Robinson W
J Reprod Med; 2005 Jul; 50(7):481-5. PubMed ID: 16130843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
